Beranda › Serangan Jantung › California
Uji klinis Serangan Jantung di California
5 studi untuk Serangan Jantung mencari peserta di lokasi di California.
Kota di California
Teks studi resmi (Bahasa Inggris)
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- National Institute of Clinical Research, Bakersfield
- California Institute of Renal Research, Chula Vista
- The Medical Research Group, Inc., Fresno
- dan 27 lainnya
Menerima pesertaFase 2/3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT05485961An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
- Cardiovascular Res Found, Beverly Hills
- National Heart Institute, Beverly Hills
- Diabetes Lipid Management Center, Huntington Beach
- dan 7 lainnya
Menerima pesertaFase 3
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT07517263OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- National Heart Institute, Beverly Hills
- 310 Clinical Research, Inglewood
- University of California San Diego, La Jolla
- dan 11 lainnya
Menerima pesertaFase 3
Usia 50 hingga 105 · Semua jenis kelamin · Diperbarui 21 Agu 2026 · NCT07136012AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
- Orange County Heart Institute, Orange
- Peerbridge Health, Pasadena
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Jun 2026 · NCT06699056Focused Orticumab Research for Treating Inflammation in Coronary Arteries
- Abcentra Investigational Site, Los Angeles
- Abcentra Investigational Site, Torrance
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Jan 2026 · NCT06927739Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.